Filing Details
- Accession Number:
- 0001177648-18-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-09 16:56:17
- Reporting Period:
- 2018-07-05
- Accepted Time:
- 2018-07-09 16:56:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1177648 | Enanta Pharmaceuticals Inc | ENTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1571211 | R. Jay Luly | C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-07-05 | 2,977 | $123.81 | 625,049 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-06 | 12,622 | $124.26 | 612,427 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-06 | 7,538 | $125.27 | 604,889 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-06 | 7,738 | $126.36 | 597,151 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-06 | 4,125 | $127.12 | 593,026 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2018.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $123.75 to $124.02, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $123.75 to $124.74, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $124.80 to $125.79, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $125.80 to $126.79, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $126.80 to $127.52, inclusive.